Physician profile
Howard Altman
NPI 1134123102
$2,099.93
in general payments reported to CMS, 2019-2025
19 companies · $355 in 2025
The $355 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2020: $141 · 2021: $367 · 2022: $197 · 2023: $451 · 2024: $347 · 2025: $355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,028 · Education: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,028.29 |
| Education | $124.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $984.33 | 2019-2025 | Xtandi |
| Janssen Biotech, INC. | $217.03 | 2019-2025 | Erleada, Tremfya |
| Sumitomo Pharma America, INC. | $160.39 | 2023-2025 | Gemtesa, Orgovyx |
| Teleflex LLC | $112.90 | 2021 | |
| Medtronic, INC. | $103.95 | 2025 | Interstim |
| Ferring Pharmaceuticals INC. | $95.03 | 2019-2024 | Adstiladrin |
| Myriad Genetic Laboratories, INC. | $90.62 | 2024-2025 | Prolaris |
| Convatec INC. | $80.55 | 2022-2024 | |
| Abbvie INC. | $34.64 | 2019-2021 | |
| Pfizer INC. | $29.69 | 2019 | |
| Cure Medical LLC | $28.06 | 2020 | |
| Merck Sharp & Dohme LLC | $27.55 | 2023 | Lynparza, Keytruda |
| Accord Healthcare, INC. | $26.93 | 2023 | |
| Neotract INC. | $21.96 | 2019 | |
| Telix Pharmaceuticals | $21.05 | 2023 | Illuccix |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $19.11 | 2024 | Xiaflex |
| Myovant Sciences INC. | $17.91 | 2022 | |
| Verity Pharmaceuticals INC. | $16.37 | 2025 | Tlando |
| Aytu Biopharma, INC. | $11.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Altman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.